The World Health Organization and NIH are involved in studies highlighting how global aging populations are creating unique healthcare challenges for companies like Roche and Novo Nordisk.

The entities involved

• National Institutes of Health →

  government organization in Shah Alam, Malaysia

  • PDS Biotechnology and the National Cancer Institute entered into a collaborative R&D agreement.Sun 13:48
  • The Trump administration seeks greater control over NIH grantmaking, while Susan Collins objects to the Office of Management and Budget's involvement.Sat 04:05
• Hoffmann-La Roche →

  Swiss healthcare company

  • Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
  • Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
• Novo Nordisk →

  company in Rome, Italy

  • Global market sentiment is being influenced by geopolitical conflict in the Middle East, impacting the competitive landscape of diabetes and obesity drug companies like Novo Nordisk and Eli Lilly.Tue 21:44
• World Health Organization →

  United Nations agency concerned with international public health

  • The U.S. ordered its withdrawal from the World Health Organization amid global health initiative impacts.Mon 11:20
  • The Ebola outbreak in the DRC is spreading to Uganda, with new cases reported in Ituri province.Mon 05:14